Cite
Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists
MLA
Anant Ramaswamy, et al. “Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists.” Indian Journal of Medical and Paediatric Oncology, vol. 40, Apr. 2019, pp. 165–71. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2d281d8bf6466bbad07edb4365ecce08&authtype=sso&custid=ns315887.
APA
Anant Ramaswamy, Pradeep Thapa, Vikas Ostwal, Shailesh V. Shrikhande, Rahul V. Parghane, Sandip Basu, Dipanjan Panda, Rohit Ranade, & Bhawna Sirohi. (2019). Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists. Indian Journal of Medical and Paediatric Oncology, 40, 165–171.
Chicago
Anant Ramaswamy, Pradeep Thapa, Vikas Ostwal, Shailesh V. Shrikhande, Rahul V. Parghane, Sandip Basu, Dipanjan Panda, Rohit Ranade, and Bhawna Sirohi. 2019. “Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists.” Indian Journal of Medical and Paediatric Oncology 40 (April): 165–71. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2d281d8bf6466bbad07edb4365ecce08&authtype=sso&custid=ns315887.